PME Signs 7-year $15M Contract with Luminis Health

22 December 2022; Company Announcement - Luminis Health - Acrobat pdf 115k Highlights PME signs 7-year, AUD $15M deal with Luminis Health Visage to replace legacy PACS throughout the Luminis Health network Contract includes Visage 7 Open Archive and Visage 7 Workflow, in addition to Visage 7 Viewer Visage 7 platform to be installed in the cloud Continues PME’s rapid expansion into North American integrated delivery networks Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a $15M 7-year contract with Luminis Health. Luminis Health, an Annapolis, Maryland based not-for-profit integrated delivery network (IDN) serves communities in central Maryland from Washington, DC to Delaware. Based on a transactional licensing model, the contract will see the company’s cloud-engineered Visage 7 Enterprise Imaging Platform (‘Visage 7’), including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout Luminis Health providing a unified diagnostic imaging platform across the network. Planning for the rollout is to commence immediately and will be based on Visage’s proven cloud-based implementation process with initial go-lives targeted for the first half of the 2023 calendar year. “IDN’s constitute the largest market segment in North America and we continue to build momentum in this segment with this, our fourth material IDN contract in the last 12 months,“ said Dr Sam Hupert, Pro Medicus CEO. “It also serves to highlight that our solution is equally well suited to mid-sized IDN’s as it is to the large ones, confirming our view that our total addressable market in the IDN space is very significant." Luminis Health joins an increasing number of new Visage clients to opt for a fully

PME Signs Three New Contracts with a Combined Minimum Value of A$16.5M and Renews University of Florida Contract in 7-year, A$15.5M Deal

29 August 2022; Company Announcement - 3 Contracts - UF Renewal - Acrobat pdf 110k Highlights Signs three new customer contracts with a combined minimum value of A$16.5M Renews a 7-year, A$15.5M contract with University of Florida Renewal negotiated at an increased fee per transaction New and renewal contracts are transaction-based with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed three new contracts with a combined minimum value of A$16.5M. The contracts are with Montage Health, a regional health system in Monterey California, Children’s Hospital of Philadelphia (CHOP), one of North America’s leading academic children’s hospitals and Bay Imaging Consultants, a private radiology group in San Francisco. All three implementations will be fully Cloud deployed and are expected to be completed within the next 6 months. The company also announced that the University of Florida (Gainesville and Jacksonville) has re-contracted for a further seven years. The deal, with a minimum contract value of A$15.5M, has been negotiated at a higher per transaction cost than the original pay per view contract. Referring to the new clients, Dr Hupert said, “These are three very different organizations which highlights the fact that our offering is ideally suited to a broad range of diagnostic imaging market segments. From a product perspective, our total addressable market (TAM) ranges from a private imaging practice in Melbourne to some of North America’s and the world’s top academic centers and anything in between.” Dr Hupert added, “With the University of Florida renewal, we have been successful in continuing our aim of 100% client retention. The fact that they have re-signed for seven years, we see as a

Dr Sam Hupert | Interview

CEO Interview - FY Results 2022 – Acrobat pdf 151k 18 August 2022 Interview with Pro Medicus CEO, Dr Sam Hupert, where he discussed: Full-year results Contract wins and renewals Margins and retained earnings Update on New York R&D Hub Pipeline

Pro Medicus Limited Full-Year Results

18 August 2022; Company Announcement - Full Year Results 2022 Final - Acrobat pdf 123k Highlights Revenue from ordinary activities $93.5m – up 37.7% Underlying profit before tax $62.4m – up 46.8% Net profit $44.4m – up 44.1% Cash and other financial assets $90.6m – up $28.8m Company remains debt-free Fully-franked final dividend 12c per share Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a full- year net profit of $44.4 million for the year to the end of June 2022, 44.1% higher than for the previous corresponding period. Revenue from ordinary activities increased by 37.7% to $93.5 million. The company's cash and other financial assets at June 30 2022 were $90.6 million, up $28.8 million, an increase of 46.5%. Pro Medicus announced a fully-franked final dividend of 12c per share, making the full year dividend 22c fully-franked, an increase of 47%. The company remains debt-free. During the year Pro Medicus announced the following key contract wins: A $40M, 7-year contract with Novant Health, Inc, a community-based Integrated Delivery Network (IDN) headquartered in North Carolina, USA, spanning three states, including 15 medical centres and hundreds of outpatient facilities and clinics. A $32M, 8-year contract with Inova Health System, the leading not-for-profit healthcare provider in Northern Virginia, USA. Inova Health’s 20,000+ team members service more than two million patient visits per year. A $28M, 7-year contract with Allina Health, a not-for-profit healthcare system based in Minneapolis, USA, which has 28,000 employees and 6,000 associated and employed physicians and operates 11 hospitals and more than 90 clinics throughout Minnesota and Wisconsin. Fourth extension of the German Government contract, Visage 7.0 being deployed to a large government hospital in the Hamburg region. Two key contract

PME Signs Two Contract Renewals with a Combined Minimum Value of A$47M

14 June 2022; Company Announcement - Sutter Health and WellSpan Health Contract Renewals - Acrobat pdf 113k Highlights Signs two contract renewals with a combined minimum value of A$47M Sutter Health renews for seven years - WellSpan Health for five Contract renewals transaction-based with potential upside Renewals negotiated at an increased fee per transaction Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed two key contract renewals with a combined value of A$47M. Sutter Health, a large IDN based in Sacramento, California has signed for a further seven years, and WellSpan Health based in Pennsylvania for a further five. Both deals are transaction-based with committed minimums and have been negotiated at a higher per transaction cost than their original contracts. "The industry norm for renewals is for short extensions to the original contract at the same or lower price," said Dr Sam Hupert, Pro Medicus CEO. "The fact that our clients have renewed for a full or longer term contract term at an increased price supports our belief that the Visage solution delivers unparalleled value both in terms of financial and clinical ROI." "Whilst it is still early days, our renewal success rate sends a positive message to the market and helps build on the network effect that we have been experiencing."

Pro Medicus Limited Signs 7-year, A$28M Contract with Allina Health

2 June 2022; Company Announcement - Allina Health - Acrobat pdf 113k Highlights PME signs 7-year, A$28M deal with Allina Health Visage to replace legacy PACS throughout the Allina Health network Contract includes Visage 7 Workflow and Visage 7 Viewer Visage 7 platform to be installed in the cloud Continues PME’s rapid expansion into North American integrated delivery networks Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a A$28M, 7-year contract with Allina Health. Allina Health, a not-for-profit health care system based in Minneapolis, Minnesota, has 28,000 employees and 6,000 associated and employed physicians and operates 11 hospitals and more than 90 clinics throughout Minnesota and Wisconsin. Based on a transactional licensing model, the contract will see the company’s Visage 7 Enterprise Imaging Platform (“Visage 7”) and Visage 7 Workflow module implemented throughout Allina Health, providing a unified diagnostic imaging platform across the network. Planning for the rollout will commence immediately and will be based on Visage’s proven cloud native implementation process with initial go-lives targeted for the second half of the calendar year. “This is our fifth major contract in the North American integrated delivery network (IDN) space in 18 months, underpinning the strong momentum we continue to build in this important segment of the market,” said Dr Sam Hupert, Pro Medicus CEO. “IDN’s are growing because of the trend towards value-based medicine coupled with industry consolidation. Our Visage 7 platform is ideally suited to meet their needs with its unparalleled speed, scalability, and proven cloud capability.” Allina Health joins an increasing number of Visage clients to opt for a fully cloud-based solution, a trend that has

PME Signs 8-year, $32M Contract with Inova Health System

8 April 2022; Company Announcement - Inova Health System - Acrobat pdf 90k Highlights PME signs 8-year, AUD $32M deal with Inova Health System Visage to replace two legacy PACS systems Contract to include Fairfax Radiology - a joint venture between Fairfax Radiological Consultants. and Inova Health System Visage 7 platform to be implemented in the public cloud Extends PME’s rapidly growing footprint in the North American Integrated Delivery Network (IDN) market Transaction-based model with potential upsideT Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a $32M, 8-year contract with Inova Health System, the leading nonprofit healthcare provider in Northern Virginia. Inova’s 20,000+ team members provide more than two million patient visits each year through an integrated network of hospitals, primary and specialty care practices, emergency and urgent care centers, outpatient services and destination institutes. Based on a transactional licensing model, the contract will see the company’s Visage 7 Enterprise Imaging Platform (“Visage 7”) implemented throughout Inova and Fairfax Radiology, providing a unified diagnostic imaging platform across both networks. Planning for the rollout is to commence immediately, with initial go-lives targeted for the second half of the calendar year. The implementation will be fully deployed in the public cloud. “This is our fourth major contract in the IDN space in less than 18 months which further underpins the strong momentum we continue to build not only in this segment of market but also the North American market as a whole,” said Dr Sam Hupert, Pro Medicus CEO. Inova also joins an increasing number of Visage clients to opt for a fully cloud-deployed solution, a trend that has taken a foothold in the

Dr Sam Hupert | Interview

CEO Interview 2021-22 Interim Results - Final – Acrobat pdf 155k 16 February 2022 Interview with Pro Medicus CEO, Dr Sam Hupert, where he discussed: First half results and recent contract wins Shift to Cloud Increased industry M&A Recent wins and pipeline  

Pro Medicus Limited Half Year Results

16 Feb 2022; Company Announcement - HY22 Results Final - Acrobat pdf 125k Highlights Revenue from ordinary activities $44.33m – up 40.3% Underlying profit before tax $28.8m – up 53.5% Net profit $20.68m – up 52.7% Cash reserves $76.17m – up $14.91m Company remains debt-free Fully franked interim dividend 10c per share – up 42.9% Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a half- year net profit of $20.68 million for the six months to the end of December 2021, 52.7% higher than for the previous corresponding period. Revenue from ordinary activities increased by 40.3% to $44.33 million. The company's cash reserves at 31 December 2021 were $76.17 million, up $14.91 million. Pro Medicus announced a final fully franked interim dividend of 10c per share. The company remains debt-free. During the six months Pro Medicus announced the following key contract wins: Novant Health (A$40 million, 7-year contract), a community-based integrated delivery network that spans three US states. Contract renewal with Allegheny Health (A$12 million, 5-year), a health network in Pittsburgh, Pennsylvania. Further extension of German government hospital to a fourth site. The company continued to make significant progress with all key implementations being on or ahead of schedule, including Intermountain and UCSF. Pro Medicus CEO Dr Sam Hupert said the result represented the strongest half-year revenue and profit results in Pro Medicus’ history, powered by contract wins and renewals in the US and an extension of a European contract to cover new regions. “We thought it was a good result with all our key financial indicators heading in the right direction, not just revenue growth but also profit growth, margin expansion and retained earnings,” he said. “There were two key drivers behind

Dr Sam Hupert | Interview

CEO Interview - Novant Health Final - Acrobat pdf 135k 4 October 2021 Interview with Pro Medicus CEO, Dr Sam Hupert, where he discussed: $40M - 7-year Novant Deal Increasing momentum and penetration of North American IDN market Cloud and Pipeline

Go to Top